Rare Eye Disease Biotech KALA BIO to Present Latest Developments at H.C. Wainwright

KALA BIO (NASDAQ:KALA), a clinical-stage biopharmaceutical company focused on developing innovative eye disease treatments, will participate in the H.C. Wainwright 27th Annual Global Investment Conference. The presentation is scheduled for September 10, 2025, at 2:00 p.m. ET in New York. Management will also be available for one-on-one meetings during the conference.

To access the webcast and subsequent archived recording of the presentation, please visit the “Presentations” section of the KALA website at www.kalarx.com.

https://www.stocktitan.net/news/KALA/kala-bio-to-present-at-h-c-wainwright-27th-annual-global-investment-33n9mwe7bqao.html

https://www.marketscreener.com/news/florida-plans-to-end-all-state-vaccine-mandates-including-for-children-to-attend-schools-wapo-repo-ce7d59dbda8bf624

https://www.zerohedge.com/geopolitical/lavrov-praises-india-not-caving-us-tariffs-pressure

https://www.bbc.com/news/articles/c4gqepe5355o

https://www.marketscreener.com/news/transcript-prokidney-corp-presents-at-citi-s-biopharma-back-to-school-conference-sep-03-2025-10-ce7d59dbdb81f023

https://www.marketscreener.com/news/pfizer-defends-covid-19-vaccine-effectiveness-after-trump-remarks-ce7d59dbd88ef124

https://www.marketscreener.com/news/transcript-cogent-biosciences-inc-presents-at-citi-s-biopharma-back-to-school-conference-sep-03-ce7d59dbda8df027